TCM
ALXN

Tekla Capital Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-64,453
Closed -$11.8M 204
2021
Q2
$11.8M Sell
64,453
-46,240
-42% -$8.49M 0.38% 68
2021
Q1
$16.9M Sell
110,693
-391,249
-78% -$59.8M 0.58% 46
2020
Q4
$78.4M Buy
501,942
+235,151
+88% +$36.7M 2.76% 6
2020
Q3
$30.5M Sell
266,791
-117,918
-31% -$13.5M 1.14% 21
2020
Q2
$43.2M Sell
384,709
-28,617
-7% -$3.21M 1.64% 16
2020
Q1
$37.1M Sell
413,326
-22,488
-5% -$2.02M 1.68% 13
2019
Q4
$47.1M Sell
435,814
-18,073
-4% -$1.95M 1.78% 13
2019
Q3
$44.5M Buy
453,887
+53,873
+13% +$5.28M 1.94% 11
2019
Q2
$52.4M Buy
400,014
+24,309
+6% +$3.18M 2.14% 11
2019
Q1
$50.8M Sell
375,705
-120,583
-24% -$16.3M 2.06% 12
2018
Q4
$48.3M Buy
496,288
+57,872
+13% +$5.63M 2.07% 12
2018
Q3
$60.9M Hold
438,416
2.21% 9
2018
Q2
$54.4M Sell
438,416
-60,559
-12% -$7.52M 2.07% 12
2018
Q1
$55.6M Sell
498,975
-160,643
-24% -$17.9M 2.16% 12
2017
Q4
$78.9M Sell
659,618
-91,287
-12% -$10.9M 3.04% 7
2017
Q3
$105M Hold
750,905
3.77% 6
2017
Q2
$91.4M Sell
750,905
-45,000
-6% -$5.48M 3.38% 9
2017
Q1
$96.5M Hold
795,905
3.74% 6
2016
Q4
$97.4M Buy
795,905
+31,900
+4% +$3.9M 4.15% 4
2016
Q3
$93.6M Buy
764,005
+82,200
+12% +$10.1M 3.6% 5
2016
Q2
$79.6M Buy
681,805
+45,000
+7% +$5.25M 3.25% 6
2016
Q1
$88.7M Hold
636,805
3.77% 5
2015
Q4
$121M Hold
636,805
4.41% 6
2015
Q3
$99.6M Buy
636,805
+52,500
+9% +$8.21M 3.58% 5
2015
Q2
$106M Buy
584,305
+82,000
+16% +$14.8M 3.82% 6
2015
Q1
$87M Buy
502,305
+25,200
+5% +$4.37M 3.45% 5
2014
Q4
$88.3M Buy
477,105
+25,200
+6% +$4.66M 4.13% 4
2014
Q3
$74.9M Buy
451,905
+116,006
+35% +$19.2M 3.51% 4
2014
Q2
$52.5M Hold
335,899
4.82% 6
2014
Q1
$51.1M Sell
335,899
-35,430
-10% -$5.39M 5.11% 6
2013
Q4
$49.4M Hold
371,329
5.19% 5
2013
Q3
$43.1M Hold
371,329
4.8% 6
2013
Q2
$34.3M Buy
+371,329
New +$34.3M 4.66% 6